{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T11:38:31Z","timestamp":1792237111655,"version":"4.4.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T00:00:00Z","timestamp":1696636800000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19H03150"],"award-info":[{"award-number":["19H03150"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K05621"],"award-info":[{"award-number":["23K05621"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.toxlet.2023.10.003","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T11:32:51Z","timestamp":1696591971000},"page":"48-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["SGX523 causes renal toxicity through aldehyde oxidase-mediated less-soluble metabolite formation in chimeric mice with humanized livers"],"prefix":"10.1016","volume":"388","author":[{"given":"Shotaro","family":"Uehara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nao","family":"Yoneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Suemizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2023.10.003_bib1","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3109\/00498254.2010.549970","article-title":"Case report of extensive metabolism by aldehyde oxidase in humans: pharmacokinetics and metabolite profile of FK3453 in rats, dogs, and humans","volume":"41","author":"Akabane","year":"2011","journal-title":"Xenobiotica"},{"key":"10.1016\/j.toxlet.2023.10.003_bib2","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1158\/1535-7163.MCT-09-0477","article-title":"SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo","volume":"8","author":"Buchanan","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.toxlet.2023.10.003_bib3","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.bcp.2015.05.010","article-title":"Interspecies differences in the metabolism of methotrexate: an insight into the active site differences between human and rabbit aldehyde oxidase","volume":"96","author":"Choughule","year":"2015","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.toxlet.2023.10.003_bib4","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1124\/dmd.110.032375","article-title":"Species-specific metabolism of SGX523 by aldehyde oxidase and the toxicological implications","volume":"38","author":"Diamond","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.toxlet.2023.10.003_bib5","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S0959-8049(02)00020-5","article-title":"Phase I and pharmacokinetic study of BIBX 1382 BS, an epidermal growth factor receptor (EGFR) inhibitor, given in a continuous daily oral administration","volume":"38","author":"Dittrich","year":"2002","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.toxlet.2023.10.003_bib6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.bbrc.2011.01.042","article-title":"The reconstituted 'humanized liver' in TK-NOG mice is mature and functional","volume":"405","author":"Hasegawa","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.toxlet.2023.10.003_bib7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10637-012-9823-9","article-title":"Unexpected renal toxicity associated with SGX523, a small molecule inhibitor of MET","volume":"31","author":"Infante","year":"2013","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.toxlet.2023.10.003_bib8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1124\/dmd.116.072793","article-title":"Lack of exposure in a first-in-man study due to aldehyde oxidase metabolism: investigated by use of 14C-microdose, humanized mice, monkey pharmacokinetics, and in vitro methods","volume":"45","author":"Jensen","year":"2017","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.toxlet.2023.10.003_bib9","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3109\/00498258409151492","article-title":"A species difference in the presystemic metabolism of carbazeran in dog and man","volume":"14","author":"Kaye","year":"1984","journal-title":"Xenobiotica"},{"key":"10.1016\/j.toxlet.2023.10.003_bib10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2133\/dmpk.21.83","article-title":"Drug-metabolizing ability of molybdenum hydroxylases","volume":"21","author":"Kitamura","year":"2006","journal-title":"Drug Metab. Pharm."},{"key":"10.1016\/j.toxlet.2023.10.003_bib11","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1158\/1078-0432.CCR-14-3258","article-title":"The c-met tyrosine kinase inhibitor JNJ-38877605 causes renal toxicity through species-specific insoluble metabolite formation","volume":"21","author":"Lolkema","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.toxlet.2023.10.003_bib12","first-page":"745","article-title":"Widespread cellular distribution of aldehyde oxidase in human tissues found by immunohistochemistry staining","volume":"16","author":"Moriwaki","year":"2001","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.toxlet.2023.10.003_bib13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/17460441.2017.1284198","article-title":"An overview of aldehyde oxidase: an enzyme of emerging importance in novel drug discovery","volume":"12","author":"Rashidi","year":"2017","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.toxlet.2023.10.003_bib14","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1007\/s00204-022-03304-3","article-title":"Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions","volume":"96","author":"Rendic","year":"2022","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2023.10.003_bib15","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/ps.4825","article-title":"Chimeric mice with humanized liver as a model for testing organophosphate and carbamate pesticide exposure","volume":"74","author":"Suemizu","year":"2018","journal-title":"Pest Manag. Sci."},{"key":"10.1016\/j.toxlet.2023.10.003_bib16","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1074\/jbc.REV119.007741","article-title":"Evolution, expression, and substrate specificities of aldehyde oxidase enzymes in eukaryotes","volume":"295","author":"Terao","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxlet.2023.10.003_bib17","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00204-016-1683-1","article-title":"Structure and function of mammalian aldehyde oxidases","volume":"90","author":"Terao","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2023.10.003_bib18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bbrc.2023.04.054","article-title":"HepaSH cells: Experimental human hepatocytes with lesser inter-individual variation and more sustainable availability than primary human hepatocytes","volume":"663","author":"Uehara","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.toxlet.2023.10.003_bib19","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1124\/dmd.122.001102","article-title":"The unique human N10-glucuronidated metabolite formation from olanzapine in chimeric NOG-TKm30 mice with humanized livers","volume":"51","author":"Uehara","year":"2023","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.toxlet.2023.10.003_bib20","article-title":"An improved TK-NOG mouse as a novel platform for humanized liver that overcomes limitations in both male and female animals","volume":"42","author":"Uehara","year":"2022","journal-title":"Drug Metab. Pharm."},{"key":"10.1016\/j.toxlet.2023.10.003_bib21","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1124\/dmd.117.076042","article-title":"Molecular cloning and characterization of marmoset aldehyde oxidase","volume":"45","author":"Uehara","year":"2017","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.toxlet.2023.10.003_bib22","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1124\/dmd.120.091090","article-title":"Human aldehyde oxidase 1-mediated carbazeran oxidation in chimeric TK-NOG mice transplanted with human hepatocytes","volume":"48","author":"Uehara","year":"2020","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.toxlet.2023.10.003_bib23","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1080\/00498254.2019.1688892","article-title":"Metabolism of desloratadine by chimeric TK-NOG mice transplanted with human hepatocytes","volume":"50","author":"Uehara","year":"2020","journal-title":"Xenobiotica"},{"key":"10.1016\/j.toxlet.2023.10.003_bib24","article-title":"Oxidative metabolism and pharmacokinetics of the EGFR inhibitor BIBX1382 in chimeric NOG-TKm30 mice transplanted with human hepatocytes","volume":"41","author":"Uehara","year":"2021","journal-title":"Drug Metab. Pharm."},{"key":"10.1016\/j.toxlet.2023.10.003_bib25","article-title":"Cytochrome P450-dependent drug oxidation activities and their expression levels in liver microsomes of chimeric TK-NOG mice with humanized livers","volume":"44","author":"Uehara","year":"2022","journal-title":"Drug Metab. Pharm."},{"key":"10.1016\/j.toxlet.2023.10.003_bib26","unstructured":"US Food and Drug Administration, 2020. Guidance for industry: safety testing of drug metabolites. (accessed 25 April 2023)."},{"key":"10.1016\/j.toxlet.2023.10.003_bib27","first-page":"15","article-title":"In silico and in vitro pharmacogenetics: aldehyde oxidase rapidly metabolizes a p38 kinase inhibitor","volume":"11","author":"Zhang","year":"2011","journal-title":"Pharm. J."}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427423010561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427423010561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T05:29:51Z","timestamp":1759901391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427423010561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":27,"alternative-id":["S0378427423010561"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2023.10.003","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SGX523 causes renal toxicity through aldehyde oxidase-mediated less-soluble metabolite formation in chimeric mice with humanized livers","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2023.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}